Free shipping on all orders over $ 500

Gandotinib

Cat. No. M3535

All AbMole products are for research use only, cannot be used for human consumption.

Gandotinib Structure
Synonym:

LY2784544

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 54 In stock
1mg USD 25 In stock
5mg USD 50 In stock
10mg USD 80 In stock
50mg USD 320 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Gandotinib (LY2784544) is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM. In the in vitro tests using Ba/F3 cells expressing either wild type or V617F mutant JAK2, Gandotinib (LY2784544) potently inhibited the JAK2 V617F-STAT5 signaling at a concentration that was 41-fold lower than that required to inhibit IL-3-activated wild type JAK2-STAT5 signaling (IC50 = 0.055 uM for JAK2 V617F vs. 2.26 uM for WT JAK2). Similarly in the proliferation assay, Gandotinib (LY2784544) selectively inhibited the JAK2 V617F-driven cell proliferation (IC50= 0.068 uM). Inhibition of JAK2 V617F signaling correlated well with the induction of apoptosis (EC50= 0.113 uM) in Ba/F3 cell model.

Customer Product Validations & Biological Datas
Source Mol Cancer Ther (2015). Figure 3. LY2784544
Method Viral knockdown
Cell Lines MCF10A cells
Concentrations 1.25 μmol/L
Incubation Time 48 h
Results Using the xCELLigence system to monitor cell growth in real time, LY2784544 had only a modest effect on MCF10A cells at 0.32, 0.63, and 1.25 μmol/L concentrations; however, the cell proliferation index was reduced in the CDH1-/- cells in a concentration-dependent manner.
Chemical Information
Molecular Weight 469.94
Formula C23H25ClFN7O
CAS Number 1229236-86-5
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jenny Dahlstrm, et al. JAK2 inhibition in JAK2 V617F-bearing leukemia cells enriches CD34 + leukemic stem cells that are abolished by the telomerase inhibitor GRN163L

[2] L Ma, et al. Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F

[3] Constantine S Tam, et al. Investigational Janus kinase inhibitors

Related JAK Products
AG490

AG490 (Tyrphostin AG490) is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 μM for EGFR and ErbB2 respectively).

AZ 960

AZ 960 is a novel and specific inhibitor of the JAK2 kinase with a Ki of 0.45nM in vitro.

Momelotinib (CYT387)

Momelotinib (CYT387) is a small-molecule, ATP-competitive JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM respectively.

TG101348

TG101348 is a selective small-molecule Janus kinase 2 (JAK2) inhibitor with IC50 of 3 nM.

WP1130

Degrasyn (WP1130) is a small molecular deubiquitinase (DUB) inhibitor and suppresses JAK-Stat signaling pathway.

  Catalog
Abmole Inhibitor Catalog




Keywords: Gandotinib, LY2784544 supplier, JAK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.